Human Immunodeficiency Virus HIV near Long Island City, NY
We found 3,237 results within 5 miles for "Human Immunodeficiency Virus HIV near Long Island City, NY"
- Appt. wasn't rushed (21)
- Listened/answered questions (21)
- Explains conditions well (21)
- View 1 more provider attributes
- Offers Telehealth
Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.
Meets the following criteria:
- Above average experience
- Good hospital quality
- Good patient ratings
- No healthcare sanctions

- Appt. wasn't rushed (6)
- Listened/answered questions (5)
- Explains conditions well (5)
- View 1 more provider attributes
- Offers Telehealth
Biography: Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University. Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as "Best Reviewer" in 2014 by The Journal of Urology and in 2016 by Cancer. Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.

- Found trustworthy (12)
- Explains conditions well (11)
- Offers Telehealth
Biography: Dr. Joseph P. Alukal is The Andrew Sabin Family Foundation Associate Professor in the Department of Urology; he is also Director of Men's Health at Columbia/NewYork-Presbyterian and Fellowship Director in Andrology/Male Reproductive Health. He serves as the Medical Director for Access-to-Care for ColumbiaDoctors. Dr. Alukal serves in a number of roles at a national and international level for professional specialty and subspecialty organizations, including the American Urological Association (AUA), the American Society for Reproductive Medicine (ASRM), and the Society for the Study of Male Reproduction (SSMR), of which he is a past-President and current Board Member. As a member of the AUA Ambassadors, he have lectured internationally to the Urologic Professional Societies of countries including India, Italy, and Bangladesh. He has authored or been a co-author on nearly 50 peer-reviewed publications and scientific book chapters and as well is the lead editor of the book "Design and Implementation of the Modern Men's Health Center." While as a fellow, he was funded by an AUA Foundation Award. Dr. Alukal currently serves at Columbia in a number of roles, including his service on the ColumbiaDoctors PO Strategy Committee. As well, he is the Clinical Director for the NYP Reproductive Tissue Bank, in addition to serving on the NYP Tissue Bank Medical Advisory Committee. He maintains a busy clinical practice in men's health, male infertility, male sexual dysfunction, and general urology and has been named to Castle Connolly's Top Doctors New York Metro Area every year since 2016. He is currently named to New York Magazine's Top Doctors 2024. He maintains extensive clinical collaborative relationships with numerous IVF centers, primary care, and cardiology practices in and around the New York City area. He has a Master's in Business Administration from Columbia Business School.
Meets the following criteria:
- Above average experience
- Good hospital quality
- Good patient ratings
- No healthcare sanctions

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth

- Offers Telehealth

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth

- Offers Telehealth

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth

- Offers Telehealth

- Offers Telehealth

- Felt Respected (1)
- LGBTQ+ affirming
- Offers Telehealth

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth

- Offers Telehealth

- Appt. wasn't rushed (10)
- Explains conditions well (10)
- Found trustworthy (10)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (6)
- Listened/answered questions (6)
- Explains conditions well (6)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth

- Offers Telehealth

- Appt. wasn't rushed (30)
- Found trustworthy (29)
- Explains conditions well (28)
- Offers Telehealth

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 2 more provider attributes

- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes

- Appt. wasn't rushed (17)
- Listened/answered questions (17)
- Explains conditions well (17)
- View 1 more provider attributes
- Offers Telehealth
